Research output per year
Research output per year
- 10 results
Search results
-
2021
Durvalumab Consolidation Should Be the Standard Therapy in Stage III EGFR-Mutant NSCLC After Chemoradiation
Morgensztern, D. & Govindan, R., Dec 2021, In: Journal of Thoracic Oncology. 16, 12, p. 1999-2001 3 p.Research output: Contribution to journal › Editorial
Open Access5 Scopus citations -
2017
TRAC(ERx)-ing lung cancer evolution
Devarakonda, S. & Govindan, R., Aug 1 2017, In: Annals of Oncology. 28, 8, p. 1690-1692 3 p.Research output: Contribution to journal › Editorial
Open Access3 Scopus citations -
2015
Epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: A decade of progress and hopeful future
Rajagopalan, K. & Govindan, R., 2015, In: Journal of Thoracic Disease. 7, 3, p. 217-219 3 p.Research output: Contribution to journal › Editorial
-
Overcoming resistance to targeted therapy for lung cancer
Govindan, R., Apr 30 2015, In: New England Journal of Medicine. 372, 18, p. 1760-1761 2 p.Research output: Contribution to journal › Editorial
24 Scopus citations -
2012
Introduction
Govindan, R., Dec 2012, In: Journal of Thoracic Oncology. 7, 16 SUPPL. 5, p. S341Research output: Contribution to journal › Editorial
Open Access -
The articles in this supplement should be viewed more as meeting reports than as exhaustive and comprehensive review articles. Introduction.
Govindan, R., Dec 2012, In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 7, 16 Suppl 5, p. S341Research output: Contribution to journal › Editorial
-
2010
INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: Yes, for EGFR mutation analysis, others, I PASS
Govindan, R., Feb 10 2010, In: Journal of Clinical Oncology. 28, 5, p. 713-715 3 p.Research output: Contribution to journal › Editorial
12 Scopus citations -
Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancer.
Govindan, R., Dec 2010, In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 5, 12 Suppl 6, p. S433Research output: Contribution to journal › Editorial
Open Access1 Scopus citations -
2009
Progress in the treatment of metastatic non-small-cell lung cancer: Slow but steady
Ramnath, N. & Govindan, R., 2009, In: Clinical Lung Cancer. 10, 4, p. 260-261 2 p.Research output: Contribution to journal › Editorial
-
2008
Small cell, big problem! Stem cells, root cause?
Subramanian, J. & Govindan, R., Sep 2008, In: Clinical Lung Cancer. 9, 5, p. 252-253 2 p.Research output: Contribution to journal › Editorial
5 Scopus citations